NKTX news

Latest 1 stories · newest Nov 5, 2026

NKTX

NKTX reports third quarter financial results and clinical updates

Nkarta Inc. reported a third-quarter 2026 net loss of $33.3 million and announced plans to present initial clinical data for NKX019 at upcoming conferences, forecasting current cash to fund operations until 2029.

Earnings Nov 5, 2026 sentiment -0.30 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same NKTX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/NKTX/newsSTART FREE